Phosphoric Acid

Phosphoric Acid

SCHEMBL2467383

CC(=O)O.O=P([O-])([O-])[O-].[K+].[K+].[K+]

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.54
LCK P06239 1/20 0.54
FYN P06241 1/20 0.54
SLC34A1 Q06495 1/20 0.47
CA4 P22748 4/20 0.44
LMNA P02545 4/20 0.41
CA1 P00915 4/20 0.40
TSHR P16473 1/20 0.33
THPO P40225 1/20 0.33
CA5A P35218 2/20 0.32
CA5B Q9Y2D0 2/20 0.32
CA2 P00918 1/20 0.31
ALOX15 P16050 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL28271586 0.96 FFAR3 (0.50) FFAR3LCKFYNSLC34A1CA4
Phosphoric Acid SCHEMBL3001932 0.92 FFAR3 (0.54) FFAR3LCKFYNSLC34A1CA4
Phosphoric Acid SCHEMBL28282273 0.92 FFAR3 (0.54) FFAR3LCKFYNSLC34A1CA4
Phosphoric Acid SCHEMBL27606778 0.92 FFAR3 (0.54) FFAR3LCKFYNSLC34A1CA4
Phosphoric Acid SCHEMBL11339920 0.92 FFAR3 (0.54) FFAR3LCKFYNSLC34A1CA4
Phosphoric Acid SCHEMBL28402400 0.92 FFAR3 (0.54) FFAR3LCKFYNSLC34A1CA4
Phosphoric Acid SCHEMBL540831 0.92 FFAR3 (0.54) FFAR3LCKFYNSLC34A1CA4
Phosphoric Acid SCHEMBL4743957 0.92 FFAR3 (0.54) FFAR3LCKFYNSLC34A1CA4
Phosphoric Acid SCHEMBL28049822 0.89 SLC34A1 (0.64) FFAR3LCKFYNSLC34A1CA4
Phosphoric Acid SCHEMBL28309432 0.89 FFAR3 (0.50) FFAR3LCKFYNSLC34A1CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101580878-B Molecular marker for distinguishing soluble acid invertase allelic variation sweet sorghum material INST CROP SCIENCE CAAS 2011-09-28 CN disclosed
US-20110223156-A1 REVERSIBLE GEL PROTEIN FORMULATION AMGEN INC. 2011-09-15 US disclosed
US-20100056765-A1 Formulations That Inhibit Protein Aggregation AMGEN INC. (US) 2010-03-04 US disclosed
CN-101580878-A Molecular marker for distinguishing soluble acid invertase allelic variation sweet sorghum material INST CROP SCIENCE CAAS (CN) 2009-11-18 CN disclosed
EP-1909838-A2 FORMULATIONS THAT INHIBIT PROTEIN AGGREGATION AMGEN INC. (US) 2008-04-16 EP disclosed
US-20070190047-A1 FORMULATIONS THAT INHIBIT PROTEIN AGGREGATION AMGEN, INC. 2007-08-16 US disclosed
WO-2007016562-A9 FORMULATIONS THAT INHIBIT PROTEIN AGGREGATION AMGEN INC (US) 2007-05-24 WO disclosed
WO-2007016562-A2 FORMULATIONS THAT INHIBIT PROTEIN AGGREGATION AMGEN INC. (US) 2007-02-08 WO disclosed